Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Deafness, Autosomal Recessive 39 × tepotinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 4 Neoplasms 2 Non-Small Cell Lung Cancer Metastatic 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Deafness, Autosomal Recessive 39 1 Colorectal Neoplasms 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

tepotinib 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04515394 2022-12-22

Study of Tepotinib Combined With Cetuximab in Participants With Left-Sided RAS/BRAF Wild Type Metastatic Colorectal Cancer (PERSPECTIVE)

EMD Serono

Phase 2 Terminated

3 enrolled 6 charts

Gastrointestinal

Deafness, Autosomal Recessive 39, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡